Want to know what Two Bear Capital's portfolio company Leapfrog Bio has been up to? Learn more about their Precision PGx Platform™. #drugdiscovery #precisionmedicine #biotechnology #TwoBearCapital
Take a closer look at our Precision PGx Platform™, a repeatable and scalable in vitro system to identify existing small-molecule drugs that can be developed to treat cancers driven by loss-of-function mutations with a high probability of clinical success. Recently featured in Nature Portfolio Precision Oncology. #drugdiscovery #precisionmedicine #biotechnology